NM_001378454.1:c.10787_10788delTG
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378454.1(ALMS1):c.10787_10788delTG(p.Val3596GlufsTer4) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. V3596V) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378454.1 frameshift
Scores
Clinical Significance
Conservation
Publications
- Alstrom syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALMS1 | NM_001378454.1 | c.10787_10788delTG | p.Val3596GlufsTer4 | frameshift_variant | Exon 16 of 23 | ENST00000613296.6 | NP_001365383.1 | |
ALMS1 | NM_015120.4 | c.10787_10788delTG | p.Val3596GlufsTer4 | frameshift_variant | Exon 16 of 23 | NP_055935.4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248654 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461756Hom.: 0 AF XY: 0.00000275 AC XY: 2AN XY: 727166 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
Alstrom syndrome Pathogenic:4
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
ACMG classification criteria: PVS1 very strong, PS4 moderated, PM2 moderated, PM3 supporting -
This sequence change creates a premature translational stop signal (p.Val3597Glufs*4) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is present in population databases (no rsID available, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with Alström syndrome (PMID: 17594715). ClinVar contains an entry for this variant (Variation ID: 556135). For these reasons, this variant has been classified as Pathogenic. -
- -
Cardiovascular phenotype Pathogenic:1
The c.10790_10791delTG pathogenic mutation, located in coding exon 16 of the ALMS1 gene, results from a deletion of two nucleotides at nucleotide positions 10790 to 10791, causing a translational frameshift with a predicted alternate stop codon (p.V3597Efs*4). This variant has been detected in the homozygous state in individuals with Alström syndrome (Marshall JD et al. Hum Mutat, 2007 Nov;28:1114-23; Piñeiro-Gallego T et al. Mol Vis, 2012 Jul;18:1794-802). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at